The observation study of ultrasonic diagnosison the liver and gallbladder damage caused by long-term use of anti-schizophrenia drugs
10.3969/j.issn.1005-1678.2017.09.157
- VernacularTitle:超声诊断对长期服用抗精神分裂药物引起肝胆损害患者的观察研究
- Author:
Wei CAI
;
Maochun LIU
- Keywords:
schizophrenia;
ultrasound;
fatty liver;
cholecystolithiasis;
chronic cholecystitis
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):352-353,356
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe and analyze the characteristics and trends of the liver and gallbladder damage caused by long-term use of anti schizophrenia drugs through the observation of the abdominal ultrasound. Methods From August 2013 to April 2016, the patients diagnosed as schizophrenia and met criterions were enrolled in our hospital. The observation group I included patients taking anti schizophrenia drug for 3 to 5 years. The observation group II included patients taking anti schizophrenia drug more than 5 years. In addition, the control group recruited healthy person who were over 30 years old and had never taken anti-schizophrenia drug. The change in ultrasound of liver and gallbladder were recorded and analyzed. Results The rate of cholecystolithiasis, chronic cholecystitis in observation group II were higher than those in the other two groups (P<0.05), while there had no significant difference between observation group I and control group. The rate of pure fatty liver in observation group II were higher than those incontrol group (P<0.05), while there had no significant difference between observation group I and observation group II, and there had no significant difference between observation group I and control group. There had no significant difference among three groups regarding as the rate of hepatic cyst and hepatic cavernous hemangioma. Conclusion Long-term use of anti-schizophrenia drugs could increase the risk ofcholecystolithiasis, chronic cholecystitis and pure fatty liver .